Rgenta Therapeutics
Charles DeLisi is Metcalf Professor of Science and Engineering at Boston University, and Dean emeritus, College of Engineering. He has authored or coauthored hundreds of research papers in various areas of science, including immunology, applied mathematics and molecular structure and function. He is recipient of numerous awards, including the Presidential Citizens Medal for initiating the Human Genome Project.
This person is not in the org chart
This person is not in any offices
Rgenta Therapeutics
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.